| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,170 |
5,092 |
$511K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,740 |
2,740 |
$484K |
| 93880 |
|
1,802 |
1,802 |
$239K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
646 |
646 |
$183K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
649 |
649 |
$120K |
| 93015 |
|
2,005 |
1,980 |
$106K |
| J2785 |
Injection, regadenoson, 0.1 mg |
657 |
655 |
$102K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,788 |
1,787 |
$80K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
547 |
547 |
$79K |
| 93000 |
|
5,987 |
5,934 |
$76K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
676 |
662 |
$49K |
| 78431 |
|
43 |
43 |
$49K |
| 93298 |
|
2,442 |
2,441 |
$43K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
42 |
42 |
$39K |
| 93922 |
|
241 |
241 |
$20K |
| 93299 |
|
199 |
199 |
$14K |
| 99406 |
|
768 |
767 |
$10K |
| 99215 |
Prolong outpt/office vis |
51 |
49 |
$7K |
| 93978 |
|
12 |
12 |
$2K |
| 93272 |
|
38 |
38 |
$1K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
27 |
24 |
$540.15 |
| 78434 |
|
43 |
43 |
$327.07 |
| 93244 |
|
12 |
12 |
$179.01 |
| 93225 |
|
12 |
12 |
$156.10 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
13 |
13 |
$87.75 |